Open at the publisher →
In force since 1993-08-11, as the publisher states.
Copy read on 2026-11-08. The page it was read from
© European Union, https://eur-lex.europa.eu
sha256 6a160923375fb6f80513135b705c238dab61e9c7d64f6fc2978bb63f8d62da58
3 provisions
Article 1
The following additional note is introduced in Chapter 29 of the combined nomenclature annexed to Regulation (EEC) No 2658/87:
‘Additional note
1. For the purposes of subheading 2937 22 00, the expression “adrenal cortical hormones” means natural adrenal cortical hormones, or those reproduced by synthesis, and their derivatives, provided that the latter certain hormone-activity.’
Propose a changeArticle 2
In the table annexed to Regulation (EEC) No 3565/88, the entry relating to item 2 (‘mometazone furoate (INNM)’) shall be deleted.
Propose a changeArticle 3
This Regulation shall enter into force on the 21st day following its publication in the Official Journal of the European Communities.
This Regulation shall be binding in its entirety and directly applicable in all Member States.
Done at Brussels, 19 July 1993.
For the Commission
Christiane SCRIVENER
Member of the Commission
(1) OJ No L 256, 7. 9. 1987, p. 1.
(2) OJ No L 158, 30. 6. 1993, p. 25.
(3) OJ No L 311, 17. 11. 1988, p. 25.
Propose a change